Company Profile

Company Overview

On March 17, 2015, Actavis completed the acquisition of Allergan, creating a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma. The combined company is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline, highly efficient operations and an experienced management team creating an unrivaled foundation for long-term growth. Join one of the world’s fastest-growing pharmaceutical companies. The combination of Actavis + Allergan is creating exciting career opportunities across our now larger and stronger global company.